Effectiveness of rimegepant in vestibular migraine: a prospective self-controlled cohort study
Jinyan Shao, Jingxin Fu, Mengting Zhou, Zewei Ren, Longxiang Li, Lili Gao, Yuhui Xia, Zexian Zhao, Mengna Yang, Jiahuan He, Siyuan Xue, Guoming Wang, Jiahui He, Kaiming Liu · 2025
Read Effectiveness of rimegepant in vestibular migraine: a prospective self-controlled cohort study by Jinyan Shao, Jingxin Fu, Mengting Zhou, Zewei Ren, Longxiang Li, Lili Gao, Yuhui Xia, Zexian Zhao, Mengna Yang, Jiahuan He, Siyuan Xue, Guoming Wang, Jiahui He, Kaiming Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750823.txt.
Description
Jinyan Shao, Kaiming Liu, and twelve co-authors test a migraine drug for vestibular migraine. Their study, from twenty twenty-five, enrolls thirty-three patients at several centers. This migraine type brings spinning dizziness and is a top cause of episodic vertigo. Good treatments are scarce, so a new option matters.
Patients took rimegepant every other day as prevention for four weeks. Each person served as their own control, comparing before and after. At the start, symptom burden was high across dizziness, mood, and balance scores. After treatment, monthly days with dizziness or headache fell a lot. Balance confidence rose as well. Longer trials can confirm the gain.
Catalog record
| CREATOR | Jinyan Shao, Jingxin Fu, Mengting Zhou, Zewei Ren, Longxiang Li, Lili Gao, Yuhui Xia, Zexian Zhao, Mengna Yang, Jiahuan He, Siyuan Xue, Guoming Wang, Jiahui He, Kaiming Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |